Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2018 | 2016 | 2015
Number of items: 8.

2022

Laakmann, E., Riecke, K., Neunhoeffer, T., Park-Simon, T-W., Weide, R., Polasik, A., Schmidt, M., Puppe, J., Fasching, P. A., Hesse, T., Decker, T., Denkert, C., Fehm, T. N., Nekljudova, V., Rey, J., Loibl, S., Mueller, V. and Witzel, I. (2022). Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry. Ann. Oncol., 33 (7). S. S660 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Laakmann, E., Riecke, K., Neunhoeffer, T., Park-Simon, T-WP, Weide, R., Polasik, A., Schmidt, M., Puppe, J., Fasching, P. A., Hesse, T., Decker, T., Denkert, C., Fehm, T., Nekljudova, V, Rey, J., Loibl, S., Mueller, V and Witzel, I (2022). Long-term survival of HER2-positive breast cancer patients with brain metastases: subanalysis of the BMBC Registry. Geburtshilfe Frauenheilkd., 82 (10). S. E113 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

2018

Zaiss, M., Uhlig, J., Zahn, M. -O, Decker, T., Lehmann, H. C., Harde, J., Hogrefe, C., Vannier, C. and Marschner, N. (2018). An observational study to evaluate the effectiveness of OnLife (R) in improving chemotherapy-induced peripheral neuropathy in patients with colon or breast cancer after end of adjuvant therapy: Final results of the STEFANO trial. Oncol. Res. Treat., 41. S. 310 - 311. BASEL: KARGER. ISSN 2296-5262

2016

Bloch, W., Baumann, F., Zimmer, P., Grischke, E-M, Fasching, P. A., Decker, T., Uleer, C., Schneeweiss, A., Salat, C., Wimberger, P., Mundhenke, C., Foerster, F., Kluth-Pepper, B., Schubert, J., Tesch, H., Schuetz, F., Lueftner, D. and Jackisch, C. (2016). Impact of physical activity/exercise on adverse events and quality of life during treatment with everolimus and exemestane for ER plus women - Results of the 3rd interim analysis of BRAWO. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Schuetz, F., Grischke, E-M, Decker, T., Uleer, C., Schneeweiss, A., Salat, C., Wimberger, P., Mundhenke, C., Foerster, F., Kluth-Pepper, B., Schubert, J., Bloch, W., Tesch, H., Jackisch, C., Idiftner, D. and Fasching, P. A. (2016). Stomatitis in patients treated with everolimus and exemestane - Results of the 3rd interim analysis of the non-interventional trial BRAWO. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Tesch, H., Grischke, E-M, Fasching, P. A., Decker, T., Uleer, C., Schneeweiss, A., Salat, C., Wimberger, P., Mundhenke, C., Foerster, F., Kluth-Pepper, B., Schubert, J., Bloch, W., Jackisch, C., Schuetz, F. and Lueftner, D. (2016). Results of the 3rd interim analysis of the non-interventional trial BRAWO - Subanalysis of patients < 70 years and >= 70 years. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

2015

Lueftner, D., Grischke, E. M., Fasching, P., Decker, T., Schneeweiss, A., Uleer, C., Foerster, F., Wimberger, P., Kluth-Pepper, B., Schubert, J., Bloch, W., Tesch, H., Schuetz, F. and Jackisch, C. (2015). Disease characteristics of subgroup patients treated with everolimus plus exemestane for < 12 months, >= 12 to < 18months, and >= 18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO. Eur. J. Cancer, 51. S. S288 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Tesch, H., Grischke, E-M, Fasching, P., Decker, T., Uleer, C., Schneeweiss, A., Foerster, F., Wimberger, P., Kluth-Pepper, B., Schubert, J., Bloch, W., Jackisch, C., Schuetz, F. and Lueftner, D. (2015). Results of the 3rd interim analysis of BRAWO - breast cancer treatment with everolimus and exemestane for ER plus women. Oncol. Res. Treat., 38. S. 252 - 254. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Mar 28 15:36:00 2024 CET.